Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome

Background The development of accurate, non‐invasive markers to diagnose and stage non‐alcoholic fatty liver disease (NAFLD) is critical to reduce the need for an invasive liver biopsy and to identify patients who are at the highest risk of hepatic and cardio‐metabolic complications. Disruption of s...

Full description

Bibliographic Details
Main Authors:	Moolla, A, de Boer, J, Pavlov, D, Amin, A, Taylor, A, Gilligan, L, Hughes, B, Ryan, J, Barnes, E, Hassan-Smith, Z, Grove, J, Aithal, GP, Verrijken, A, Francque, S, Van Gaal, L, Armstrong, MJ, Newsome, PN, Cobbold, JF, Arlt, W, Biehl, M, Tomlinson, JW
Format:	Journal article
Language:	English
Published:	Wiley 2020

Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome

Similar Items